Pfizer’s Goettler On What Partners Look For In Orphan Drug Deals
Executive Summary
Michael Goettler, Pfizer's global president, rare disease global innovative pharma business, offers tips to Korean orphan drug developers on reaching out to potential partners successfully and what Pfizer is looking for in rare disease deals.